1. Home
  2. OBIO vs FRGE Comparison

OBIO vs FRGE Comparison

Compare OBIO & FRGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OBIO
  • FRGE
  • Stock Information
  • Founded
  • OBIO 2017
  • FRGE 2014
  • Country
  • OBIO United States
  • FRGE United States
  • Employees
  • OBIO N/A
  • FRGE N/A
  • Industry
  • OBIO Medicinal Chemicals and Botanical Products
  • FRGE Computer Software: Prepackaged Software
  • Sector
  • OBIO Health Care
  • FRGE Technology
  • Exchange
  • OBIO Nasdaq
  • FRGE Nasdaq
  • Market Cap
  • OBIO 291.7M
  • FRGE 302.3M
  • IPO Year
  • OBIO N/A
  • FRGE N/A
  • Fundamental
  • Price
  • OBIO $8.03
  • FRGE $1.51
  • Analyst Decision
  • OBIO Strong Buy
  • FRGE Buy
  • Analyst Count
  • OBIO 2
  • FRGE 2
  • Target Price
  • OBIO $17.00
  • FRGE $5.25
  • AVG Volume (30 Days)
  • OBIO 248.3K
  • FRGE 417.4K
  • Earning Date
  • OBIO 08-08-2024
  • FRGE 08-06-2024
  • Dividend Yield
  • OBIO N/A
  • FRGE N/A
  • EPS Growth
  • OBIO N/A
  • FRGE N/A
  • EPS
  • OBIO N/A
  • FRGE N/A
  • Revenue
  • OBIO $2,216,000.00
  • FRGE $73,584,000.00
  • Revenue This Year
  • OBIO $17.90
  • FRGE $27.87
  • Revenue Next Year
  • OBIO $10.51
  • FRGE $36.74
  • P/E Ratio
  • OBIO N/A
  • FRGE N/A
  • Revenue Growth
  • OBIO N/A
  • FRGE 13.49
  • 52 Week Low
  • OBIO $4.22
  • FRGE $1.31
  • 52 Week High
  • OBIO $11.69
  • FRGE $4.02
  • Technical
  • Relative Strength Index (RSI)
  • OBIO 54.75
  • FRGE 50.49
  • Support Level
  • OBIO $7.80
  • FRGE $1.36
  • Resistance Level
  • OBIO $8.87
  • FRGE $1.63
  • Average True Range (ATR)
  • OBIO 0.60
  • FRGE 0.08
  • MACD
  • OBIO -0.01
  • FRGE 0.02
  • Stochastic Oscillator
  • OBIO 59.02
  • FRGE 54.81

About OBIO Orchestra BioMed Holdings Inc.

Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.

About FRGE Forge Global Holdings Inc.

Forge Global Holdings Inc is a financial service platform created to serve the needs of the private market. It provides marketplace infrastructure, data services, and technology solutions for private market participants. The Company offers a trusted trading platform, proprietary data and insights to inform investment strategies, along with custody services to help companies, shareholders, institutions and accredited investors confidently navigate and transact in the private market.

Share on Social Networks: